Patents by Inventor Jennifer Grace Abelin

Jennifer Grace Abelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HLA-based methods and compositions and uses thereof
    Patent number: 11965892
    Abstract: Systems, compositions, and methods for isolating HLA-peptides from cells. A universal platform and methods for profiling the HLA-peptidome, enabling identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: April 23, 2024
    Assignee: BioNTech US Inc.
    Inventors: Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
  • HLA-BASED METHODS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20230384320
    Abstract: Compositions and methods for isolating HLA-peptides from cells. A universal platform and methods for profiling the HLA-peptidome, enabling identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct.
    Type: Application
    Filed: March 28, 2023
    Publication date: November 30, 2023
    Inventors: Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
  • HLA-based methods and compositions and uses thereof
    Patent number: 11650211
    Abstract: Compositions and methods for isolating HLA-peptides from cells. A universal platform and methods for profiling the HLA-peptidome, enabling identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: May 16, 2023
    Assignee: BioNTech US INC.
    Inventors: Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
  • METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS
    Publication number: 20220199198
    Abstract: Methods for preparing a personalized cancer vaccine and a method to train a machine-learning HLA-peptide presentation prediction model.
    Type: Application
    Filed: October 6, 2021
    Publication date: June 23, 2022
    Inventors: Michael Steven Rooney, Jennifer Grace Abelin, Dominik Barthelme, Robert Kamen
  • Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cells
    Patent number: 11183272
    Abstract: Methods for preparing a personalized cancer vaccine and a method to train a machine-learning HLA-peptide presentation prediction model.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: November 23, 2021
    Assignee: BIONTECH US INC.
    Inventors: Michael Steven Rooney, Jennifer Grace Abelin, Dominik Barthelme, Robert Kamen
  • METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS
    Publication number: 20200279616
    Abstract: The present disclosure provides method for preparing a personalized cancer vaccine. The present disclosure also provides a method to train a machine-learning HLA-peptide presentation prediction model.
    Type: Application
    Filed: March 19, 2020
    Publication date: September 3, 2020
    Inventors: Michael Steven Rooney, Jennifer Grace Abelin, Dominik Barthelme, Robert Kamen
  • HLA-BASED METHODS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20200105378
    Abstract: The present disclosure provides compositions and methods for isolating HLA-peptides from cells. The present disclosure provides a universal platform and methods for profiling the HLA-peptidome, enabling identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct.
    Type: Application
    Filed: November 22, 2019
    Publication date: April 2, 2020
    Inventors: Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
  • HLA-BASED METHODS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20200096521
    Abstract: The present disclosure provides compositions and methods for isolating HLA-peptides from cells. The present disclosure provides a universal platform and methods for profiling the HLA-peptidome, enabling identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct.
    Type: Application
    Filed: February 2, 2018
    Publication date: March 26, 2020
    Inventors: Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney